(Press-News.org) A new study published in Nature Genetics by the Lymphoid Development Group at the MRC Laboratory of Medical Sciences has reveals that the contribution of cells expressing maternal or paternal X chromosomes can be selectively skewed in different parts of the body. The study leverages human data from the 1000 Genomes Project combined with mouse models of human X chromosome-linked DNA sequence variation to advance our fundamental understanding of development in biologically female individuals who have two X chromosomes.
Until now, it was thought that the usage of maternal and paternal X-chromosomes was similar throughout the body. The new work shows that this is not always true, and that different organs may be skewed towards using either maternal or paternal X-chromosomes. The work also reveals the process driving this skew: competition between cells expressing either one or the other X-chromosome. In some individuals, cells in organs such as the heart mostly use the X chromosome from one parent, whereas immune cells almost exclusively utilise the X chromosome from the other parent. This provides an important step forward in understanding the underlying principles and mechanisms of development in XX individuals.
Biological females inherit two X chromosomes – one from each parent – along with all the other genetic material that builds and sustains the body. But despite the presence of both parental X chromosomes, only one X chromosome is actively expressed in any given cell. Since the DNA sequence of each X chromosome has genetic variations, each cell effectively chooses to express a set of unique characteristics derived from either one or the other parent.
“We realised that when cells chose one of their two X chromosomes over the other, they also chose which set of genetic variants to express” said Matthias Merkenschlager, who leads the Lymphocyte Development Research Group. “As a result, individual cells express distinct genetic variants. We are now working to find out more about how X-linked genetic variants shape organismal development, and whether selective X chromosome usage in specific tissues may affect the likelihood of certain conditions later in life.”
The researchers focussed on a specific gene on the X chromosome, called STAG2. They found that cells with a genetic variant of STAG2 failed to develop into immune cells called lymphocytes in females that carried variant STAG2 on one X chromosome, and the common ('reference') version of STAG2 on the other X chromosome.
By contrast, cells with the same variant of STAG2 were fully competent to form lymphocytes in XY males (with a single copy of the X chromosome), or females in which both X chromosomes carried the variant.
The researchers concluded that what prevents variant cells from forming lymphocytes is not the variant as such, but the presence of cells expressing the reference version of STAG2. This shows that cells compete for 'permission' to form specific cell types within the body. The findings reveal a new aspect of X-linked diversity not previously appreciated: that interactions between cells can shape the contribution of X-linked diversity to specific cell types and tissues.
Even if cells expressing reference STAG2 outcompete to form the blood, cells expressing the variant may predominate in other parts of the body. For the study’s lead author Teresa Buenaventura, this sparked a personal curiosity: “'Working on this project has been particularly exciting for me since it has made me curious about the contribution of each of the X chromosomes to my different tissues,” she said.
These findings reveal a previously underappreciated aspect of X-linked diversity, where interactions between epigenetically diverse clones can shape the contribution of X-linked genetic diversity to specific cell types and tissues.
END
"Just like your mother?" Maternal and paternal X-chromosomes show skewed distribution in different organs and tissues.
2024-07-26
ELSE PRESS RELEASES FROM THIS DATE:
Conflicting health advice from agencies drives confusion, study finds, but doctors remain most trusted
2024-07-26
Distrust of health experts and credulity towards misinformation can kill. For example, during the Covid-19 crisis, high-profile health experts received death threats while misinformation went viral on social media. And already long before the pandemic, easily preventable but potentially serious diseases had been making a comeback around the world due to vaccine hesitancy – often powered by conspiracy theories.
But what feeds this lack in trust in reliable sources of health information? Can it perhaps be mitigated? Those are the subjects of a new study in Frontiers in Medicine by researchers from the US.
“Here we show that individuals who ...
Towards next-gen indoor lighting: novel tunable ultrasonic liquid crystal light diffuser
2024-07-26
It is no mystery that light is essential to human life. Since the discovery of fire, humans have developed various artificial light sources, such as incandescent lamps, gaslights, discharge lamps, and light-emitting diodes (LEDs). The distribution and intensity of artificial lights indoors are important factors that affect our ability to study and work effectively and influence our physical and mental health. Consequently, modern artificial light sources are designed with these psychological elements to achieve the best aesthetics. ...
Chinese medicinal fungus shows promise in treating idiopathic pulmonary fibrosis
2024-07-26
A recent study from China has reported that Cordyceps sinensis (CS), a traditional Chinese medicinal fungus, can ameliorate idiopathic pulmonary fibrosis (IPF) in mice by inhibiting mitochondrion-mediated oxidative stress. The research, conducted by a team led by Huan Tang and Jigang Wang from the Institute of Chinese Materia Medica at the China Academy of Chinese Medical Sciences, was published in Wiley's MedComm-Future Medicine.
Idiopathic pulmonary fibrosis is a chronic and progressive lung disease characterized by a decline in lung function, ultimately leading to respiratory failure and a significantly reduced quality of life for patients. With a median ...
Shining light on similar crystals reveals photoreactions can differ
2024-07-26
A rose by any other name is a rose, but what of a crystal? Osaka Metropolitan University-led researchers have found that single crystals of four anthracene derivatives with different substituents react differently when irradiated with light, perhaps holding clues to how we can use such materials in functional ways.
Graduate student Sogo Kataoka, Dr. Daichi Kitagawa, a lecturer, and Professor Seiya Kobatake of the Graduate School of Engineering and colleagues compared the photoreactions of the single crystals when the entire anthracene crystal was irradiated with light.
For two ...
Innovative fire stewardship techniques to reshape landscape design to better adapt to and coexist with wildfire-prone environments
2024-07-26
Over the past few decades, many parts of the world have experienced record-breaking wildfire events—a trend that is, unfortunately, expected to rise. These extreme events not only result in mass evacuations, but also release greenhouse gases like carbon dioxide, pose risks to life, devastate buildings and essential infrastructure, and fundamentally disrupt and detrimentally transform native ecosystems. In response to the increased risk of catastrophic wildfires, many planning and site design practices have sought to protect the trends and status quo of land development. These measures strive to resist and, ...
Kepler’s 1607 pioneering sunspot sketches solve solar mysteries 400 years later
2024-07-26
Using modern techniques, researchers have re-examined Johannes Kepler's half-forgotten sunspot drawings and revealed previously hidden information about the solar cycles before the grand solar minimum. By recreating the conditions of the great astronomer’s observations and applying Spörer's law in the light of modern statistics, an international collaborative group led by Nagoya University in Japan has measured the position of Kepler’s sunspot group, placing it at the tail-end of the solar cycle before the cycle that Thomas Harriot, Galileo Galilei, and other ...
A new therapeutic target offers a promising pathway for multiple sclerosis treatment
2024-07-26
Fukuoka, Japan – Researchers from Kyushu University have identified a potential therapeutic target for the treatment of advanced multiple sclerosis (MS), a potentially disabling condition associated with the central nervous system. In their latest study, conducted using an experimental mouse model of MS, they explored the role of connexin 43 (Cx43), a protein involved in cellular communication and cardiac function, and examined whether targeting this protein with specific blockers could improve ...
Recent insights and advances in treatment and management show promise in stemming the growing prevalence of diabetes
2024-07-26
A new paper surveying advances in diabetes pathogenesis and treatment explores the complex factors contributing to the onset and progression of the disease, suggesting that an understanding of these dynamics is key to developing targeted interventions to reduce the risk of developing diabetes and managing its complications.
In a paper published July 25 in a special 50th anniversary issue of the peer-reviewed journal Cell, the authors surveyed hundreds of studies that have emerged over the years looking at the causes underpinning types 1 (T1D) and 2 (T2D) diabetes and new treatments for the disease. They examine the role that genes, environmental factors, and ...
Folded peptides are more electrically conductive than unfolded peptides
2024-07-26
What puts the electronic pep in peptides? A folded structure, according to a new study in the Proceedings of the National Academy of Sciences.
Electron transport, the energy-generating process inside living cells that enables photosynthesis and respiration, is enhanced in peptides with a collapsed, folded structure. Interdisciplinary researchers at the Beckman Institute for Advanced Science and Technology combined single-molecule experiments, molecular dynamics simulations and quantum mechanics to validate their findings.
“This discovery provides a new understanding of how electrons flow through peptides ...
Biotechnology companies can sustain the pipeline of new drugs under the Inflation Reduction Act
2024-07-26
BENTLEY UNIVERSITY
New research from the Center for Integration of Science and Industry at Bentley University shows that differences between the financial structures of large pharmaceutical producers and smaller, emerging biotechnology companies creates synergies that contribute to the pipeline of new, innovative products in response to reductions in drug prices anticipated under the Inflation Reduction Act (IRA). While large pharmaceutical producers would likely reduce R&D spending in response to lower product revenues, R&D in smaller biotechnology companies is not likely to decrease and could sustain both corporate profits and new product ...